Smithfield Trust’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8K Hold
148
﹤0.01% 929
2025
Q4
$9K Hold
148
﹤0.01% 902
2025
Q3
$8K Hold
148
﹤0.01% 905
2025
Q2
$8K Sell
148
-64
-30% -$3.22K ﹤0.01% 903
2025
Q1
$13K Hold
212
﹤0.01% 815
2024
Q4
$16K Hold
212
﹤0.01% 793
2024
Q3
$17K Hold
212
﹤0.01% 759
2024
Q2
$16K Hold
212
﹤0.01% 751
2024
Q1
$15K Hold
212
﹤0.01% 780
2023
Q4
$16K Sell
212
-52
-20% -$3.42K ﹤0.01% 755
2023
Q3
$19K Hold
264
﹤0.01% 689
2023
Q2
$21K Hold
264
﹤0.01% 687
2023
Q1
$20K Hold
264
﹤0.01% 666
2022
Q4
$21K Hold
264
﹤0.01% 643
2022
Q3
$20K Hold
264
﹤0.01% 641
2022
Q2
$24K Hold
264
﹤0.01% 643
2022
Q1
$29K Hold
264
﹤0.01% 637
2021
Q4
$35K Hold
264
﹤0.01% 618
2021
Q3
$31K Hold
264
﹤0.01% 635
2021
Q2
$30K Hold
264
﹤0.01% 629
2021
Q1
$25K Hold
264
﹤0.01% 670
2020
Q4
$21K Hold
264
﹤0.01% 669
2020
Q3
$16K Buy
264
+148
+128% +$9.63K ﹤0.01% 675
2020
Q2
$8K Buy
116
+64
+123% +$3.83K ﹤0.01% 784
2020
Q1
$2K Buy
+52
New +$2.6K ﹤0.01% 887

Other funds holding TECH

Smithfield Trust's TECH Position: Q1 2026 in Review

Smithfield Trust held its Bio-Techne (TECH) position steady in Q1 2026 at 148 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #929.

Smithfield Trust first reported a position in TECH in Q1 2020 and has held it in 25 quarters since. The position peaked at $35K in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Smithfield Trust held 148 shares of Bio-Techne worth $8K as of Q1 2026.
  • Smithfield Trust left its Bio-Techne share count unchanged in Q1 2026.
  • Bio-Techne made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #929 holding.
  • Smithfield Trust first reported a position in Bio-Techne in Q1 2020 and has held it in 25 quarters since.
  • Smithfield Trust's Bio-Techne position peaked at $35K in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.